He moved from Nigeria to middle England and was swept up into the rave scene – then battled through incarceration and near-death illness. After making 500 tracks while living on porridge and lettuce, he explains how he kept going Ibrahim Alfa Jr had been feeling unwell for a while – he’d been coughing up blood – but he says he only realised how ill he was when the facial recognition on his phone s...
He moved from Nigeria to middle England and was swept up into the rave scene – then battled through incarceration and near-death illness. After making 500 tracks while living on porridge and lettuce, he explains how he kept going Ibrahim Alfa Jr had been feeling unwell for a while – he’d been coughing up blood – but he says he only realised how ill he was when the facial recognition on his phone stopped working, because it could no longer recognise his face. When he went to visit his sister in 2022, she was so shocked by his appearance, she took him straight to A&E. He was suffering from anaphylaxis, a severe and potentially fatal allergic reaction: moreover, he had a pulmonary embolism that was causing his lung to fill up with blood. “I thought: oh my God, that’s literally what killed Andy Weatherall, ” he says today. Like Weatherall once was, Alfa Jr is a veteran star of British rave culture. “So, like, wow .” The embolism treated, he was sent home, but still wasn’t feeling right. The weekend after, a second pulmonary embolism was found on his other lung. The weekend after that, he had a heart attack. Then he had a second heart attack. Returning home, he discovered he’d become “allergic to everything. Even water was swelling my face,” he says. “You just don’t know what you can eat, so I just lived on porridge and lettuce leaves for three months, and didn’t see anybody. I just locked myself in a room, and a friend would bring me porridge and lettuce leaves. I only went out to go to the doctors. Any type of social life, of seeing other humans just disappeared. It was that visceral.” Continue reading...
Marc Lichtenfeld highlights HAL, CVX, and HASI as energy stocks positioned to benefit from AI-driven electricity demand growth forecast at 3.5% annually through 2030.
Marc Lichtenfeld highlights HAL, CVX, and HASI as energy stocks positioned to benefit from AI-driven electricity demand growth forecast at 3.5% annually through 2030.
courtneyk Stock futures edged lower Monday morning while crude oil prices marched higher as Wall Street faced a dual threat from escalating geopolitical conflict and mounting tech skepticism. Here are some of Monday's biggest stock movers: Biggest stock gainers Nurix Therapeutics ( NRIX ) +38% – Shares skyrocketed after the biotech announced an exclusive global licensing and collaboration agreemen...
courtneyk Stock futures edged lower Monday morning while crude oil prices marched higher as Wall Street faced a dual threat from escalating geopolitical conflict and mounting tech skepticism. Here are some of Monday's biggest stock movers: Biggest stock gainers Nurix Therapeutics ( NRIX ) +38% – Shares skyrocketed after the biotech announced an exclusive global licensing and collaboration agreement with Swiss pharma giant Roche (RHHBY) valued at up to $2.3B to develop and commercialize bexobrutideg. Nurix will receive a massive $700M upfront cash payment and remains eligible for future development, regulatory, and sales milestones for the oral BTK degrader. Under the agreement, Roche will fund 60% of development costs and Nurix 40%, with the companies sharing U.S. profits and losses equally alongside a co-commercialization framework. Outside the U.S., Roche will handle commercial duties and pay Nurix tiered royalties in the low- to high-teens. Investors reacted positively to the substantial non-dilutive funding and the broad pipeline strategy, which aims for the initiation of a Phase 3 trial this summer in chronic lymphocytic leukemia (CLL), while also expanding into multiple sclerosis (MS) and chronic spontaneous urticaria ( CSU ). Eli Lilly ( LLY ) +5% - Shares advanced after the company presented new analyses from its late-stage ATTAIN-1 and ATTAIN-2 trials showing that its investigational obesity drug Foundayo delivered significant weight loss in women regardless of whether they were premenopausal, perimenopausal, or postmenopausal. In ATTAIN-1, women on the highest dose lost 12.8% to 14.4% of body weight over 72 weeks, while up to 83% achieved at least 5% weight loss and as many as 52% lost 15% or more. The findings highlight the drug's potential effectiveness in a large and often understudied population, reinforcing Lilly's leadership in the obesity market and supporting future physician adoption and reimbursement discussions. Investors welcomed the data as it...
英伟达CEO黄仁勋上周开启了韩国首尔之行，将做客韩国热门综艺节目《You Quiz on the Block》。 根据该节目放出的预热内容，黄仁勋在院子里随着动画电影《K-POP：猎魔女团》的主题曲《Golden》起舞，依然穿着他标志性的皮夹克。 在预告中，黄仁勋与主持人刘在石对谈，表示他喜欢《Golden》这首歌。 黄仁勋的全球首次综艺脱口秀备受期待，本期《You Quiz on the Blo...
英伟达CEO黄仁勋上周开启了韩国首尔之行，将做客韩国热门综艺节目《You Quiz on the Block》。 根据该节目放出的预热内容，黄仁勋在院子里随着动画电影《K-POP：猎魔女团》的主题曲《Golden》起舞，依然穿着他标志性的皮夹克。 在预告中，黄仁勋与主持人刘在石对谈，表示他喜欢《Golden》这首歌。 黄仁勋的全球首次综艺脱口秀备受期待，本期《You Quiz on the Block》节目将于当地时间6月10日晚上8:45播出（北京时间晚上7:45）。 综合IT之家此前报道，黄仁勋在6月5日抵达韩国后，先和电竞选手Faker进行了会面，然后和多位韩企掌门人在烤肉店共进晚餐，还会见了韩国KRAFTON、NCSoft 游戏 厂商代表。
Brookfield Head of AI Infrastructure and Head of Europe Sikander Rashid joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg Brief. (Source: Bloomberg)
Brookfield Head of AI Infrastructure and Head of Europe Sikander Rashid joins Bloomberg's Tom Mackenzie to kick off London Tech Week as part of Bloomberg Brief. (Source: Bloomberg)